Asterand to acquire BioSeek



18 November 2009 @ 09:11 am BST

Asterand has signed an agreement to acquire BioSeek, a pioneer in the application of predictive human biology to drug discovery through its human primary cell based disease models.

The deal is subject to Asterand shareholders' approval. Asterand said it achieved revenue of £9.1m in the nine months to the end of September compared with £8m last year - excluding the licensing payments from Allergan.

Revenues for the same period last year also contained £1.1m relating to a one year contract that ended in December 2008.

The company said it continued to control its expenditures while maintaining strong cash resources of £5.2m (30 June: £5.8m).

Story provided by Business Financial Newswire

© 2010 Stockmarketwire.com. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Click!
  • Rate this article:

Comments

Post Your Comment

*Name


Most Popular Markets

 
 
IBTimes © 2012 IBTimes Company. All Rights Reserved. Partners